Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,144 | 389 | 84.3% |
| Education | $915.58 | 13 | 10.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 3.5% |
| Gift | $118.80 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,509 | 31 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $762.45 | 39 | $0 (2022) |
| Novo Nordisk Inc | $721.66 | 67 | $0 (2023) |
| MannKind Corporation | $555.17 | 24 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $435.21 | 29 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $401.83 | 16 | $0 (2022) |
| Lilly USA, LLC | $340.00 | 27 | $0 (2024) |
| Corcept Therapeutics | $324.06 | 7 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $321.91 | 12 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $316.30 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $400.18 | 16 | Bayer Healthcare Pharmaceuticals Inc. ($183.64) |
| 2023 | $477.04 | 11 | Renalytix AI, Inc. ($188.02) |
| 2022 | $1,340 | 33 | Amgen Inc. ($812.33) |
| 2021 | $299.13 | 20 | Merck Sharp & Dohme Corporation ($53.22) |
| 2020 | $442.76 | 10 | Tandem Diabetes Care, Inc. ($319.47) |
| 2019 | $1,345 | 55 | Amgen Inc. ($263.14) |
| 2018 | $1,808 | 107 | AstraZeneca Pharmaceuticals LP ($263.54) |
| 2017 | $2,366 | 153 | Amgen Inc. ($306.86) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Cardio-renal | ||||||
| 06/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: Cardio-renal | ||||||
| 06/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Cardio-renal | ||||||
| 05/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 05/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Cardio-renal | ||||||
| 05/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Endocrinology | ||||||
| 04/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $94.33 | General |
| Category: Cardio-renal | ||||||
| 04/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Cardio-renal | ||||||
| 04/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Education | In-kind items and services | $26.88 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $124.97 | General |
| Category: ACROMEGALY | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Cardio-renal | ||||||
| 11/20/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: non-opioid analgesic | ||||||
| 10/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 10/10/2023 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: ENDOCRINE AGENT | ||||||
| 08/14/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 08/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 07/01/2023 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $188.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/24/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: DIABETES MEDICINE | ||||||
| 06/20/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $136.35 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,419 | 4,589 | $437,468 | $203,331 |
| 2022 | 10 | 1,456 | 3,772 | $457,355 | $215,511 |
| 2021 | 11 | 1,383 | 2,400 | $387,015 | $200,156 |
| 2020 | 11 | 1,472 | 2,407 | $380,654 | $167,818 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 763 | 1,343 | $268,558 | $117,738 | 43.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 26 | 2,160 | $47,500 | $36,857 | 77.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 121 | $23,595 | $15,327 | 65.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 158 | 340 | $33,950 | $8,634 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 123 | $15,990 | $7,079 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $14,700 | $5,023 | 34.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 38 | 42 | $9,660 | $4,144 | 42.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 39 | 39 | $7,800 | $3,296 | 42.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 90 | 264 | $7,920 | $2,604 | 32.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,625 | $2,372 | 42.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $510.00 | $161.84 | 31.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 31 | 83 | $1,660 | $92.99 | 5.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 770 | 1,449 | $289,800 | $132,410 | 45.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,260 | $27,385 | $21,348 | 78.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 92 | 110 | $21,450 | $16,024 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 203 | $26,390 | $13,456 | 51.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 163 | 364 | $36,400 | $9,837 | 27.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 59 | 67 | $15,410 | $7,014 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $19,600 | $6,616 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $8,250 | $3,899 | 47.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 32 | 32 | $6,400 | $2,689 | 42.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 65 | 209 | $6,270 | $2,217 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 773 | 1,520 | $262,024 | $145,762 | 55.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 84 | $18,497 | $11,052 | 59.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 72 | 72 | $25,200 | $9,186 | 36.5% |
About Dr. Brian Berelowitz, MD
Dr. Brian Berelowitz, MD is a Specialist healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356308357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Berelowitz, MD has received a total of $8,478 in payments from pharmaceutical and medical device companies, with $400.18 received in 2024. These payments were reported across 405 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,144).
As a Medicare-enrolled provider, Berelowitz has provided services to 5,730 Medicare beneficiaries, totaling 13,168 services with total Medicare billing of $786,815. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism
- Location Las Vegas, NV
- Active Since 04/26/2006
- Last Updated 01/23/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1356308357
Products in Payments
- Repatha (Biological) $1,083
- FARXIGA (Drug) $699.71
- AFREZZA (Drug) $555.17
- TOUJEO (Drug) $334.52
- Korlym (Drug) $324.06
- t:slim X2 insulin pump (Device) $319.47
- Kerendia (Drug) $316.30
- Tymlos (Biological) $252.68
- Minimed 670G System (Device) $232.97
- Prolia (Biological) $230.22
- JANUVIA (Drug) $201.48
- Ozempic (Drug) $197.16
- SOMAVERT (Drug) $191.44
- Victoza (Drug) $188.04
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $188.02
- Androgel (Drug) $175.01
- TRULICITY (Drug) $168.69
- Omnipod (Device) $151.25
- MYCAPSSA (Drug) $150.56
- JARDIANCE (Drug) $149.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Las Vegas
Dr. Mehdi Ansarinia, Md, MD
Specialist — Payments: $347,145
George Kelly, Md, MD
Specialist — Payments: $305,649
Dr. Galen Kam, M.d, M.D
Specialist — Payments: $184,471
Molouk Rahnema, Md, MD
Specialist — Payments: $149,593
Dr. Steven Leibowitz, M.d, M.D
Specialist — Payments: $135,214
Edward Zimmerman, M.d, M.D
Specialist — Payments: $98,329